Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 4, 2022
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
Anupam Rama Maintained (APLS) at Buy with Increased Target to $69 on, Apr 4th, 2022
Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $66 to $69 on, Apr 4th, 2022.
Anupam has made no other calls on APLS in the last 4 months.
There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Anupam's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Anupam
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $86 on, Monday, March 7th, 2022
- Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $112 on, Tuesday, January 11th, 2022
- Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $84 on, Wednesday, December 8th, 2021
